Towards a malaria vaccine for Papua New Guinea.
Malaria is a major problem in Papua New Guinea, where it accounts for a high proportion of sickness and death. In addition to the human suffering, malaria also puts severe stress on the health services, and may directly hinder economic growth. A malaria vaccine would be the best, most cost-effective and safest public health measure to reduce the burden of malaria. Though considerable technical challenges are present, much natural and scientific evidence suggests a vaccine is achievable. Through the malaria vaccine program at the Papua New Guinea Institute of Medical Research, Papua New Guinea is playing a significant role in the global effort to develop a malaria vaccine, and ensuring that the malaria patterns of the Asia-Pacific region figure strongly in vaccine development strategies. Discussed here are some of the major issues to be considered as we work towards a malaria vaccine for Papua New Guinea.
Reeder
J C
JC
D003906:Developing Countries; D019353:Endemic Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D015994:Incidence; D007391:International Cooperation; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D010219:Papua New Guinea / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D012424:Rural Population; D014611:Vaccination / Q000379:methods
D017780:Malaria Vaccines